• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析人工智能在慢性阻塞性肺疾病(COPD)管理中的应用。

Analyzing the use of artificial intelligence for the management of chronic obstructive pulmonary disease (COPD).

作者信息

De Ramón Fernández Alberto, Ruiz Fernández Daniel, Gilart Iglesias Virgilio, Marcos Jorquera Diego

机构信息

Department of Computer Technology, University of Alicante, Alicante 03690, Spain.

Department of Computer Technology, University of Alicante, Alicante 03690, Spain.

出版信息

Int J Med Inform. 2021 Nov 9;158:104640. doi: 10.1016/j.ijmedinf.2021.104640.

DOI:10.1016/j.ijmedinf.2021.104640
PMID:34890934
Abstract

OBJECTIVE

Chronic obstructive pulmonary disease (COPD) is a disease that causes airflow limitation to the lungs and has a high morbidity around the world. The objective of this study was to evaluate how artificial intelligence (AI) is being applied for the management of the disease, analyzing the objectives that are raised, the algorithms that are used and what results they offer.

METHODS

We conducted a scoping review following the Arksey and O'Malley (2005) and Levac et al. (2010) guidelines. Two reviewers independently searched, analyzed and extracted data from papers of five databases: Web of Science, PubMed, Scopus, Cinahl and Cochrane. To be included, the studies had to apply some AI techniques for the management of at least one stage of the COPD clinical process. In the event of any discrepancy between both reviewers, the criterion of a third reviewer prevailed.

RESULTS

380 papers were identified through database searches. After applying the exclusion criteria, 67 papers were included in the study. The studies were of a different nature and pursued a wide range of objectives, highlighting mainly those focused on the identification, classification and prevention of the disease. Neural nets, support vector machines and decision trees were the AI algorithms most commonly used. The mean and median values of all the performance metrics evaluated were between 80% and 90%.

CONCLUSIONS

The results obtained show a growing interest in the development of medical applications that manage the different phases of the COPD clinical process, especially predictive models. According to the performance shown, these models could be a useful complementary tool in the decision-making by health specialists, although more high-quality ML studies are needed to endorse the findings of this study.

摘要

目的

慢性阻塞性肺疾病(COPD)是一种导致肺部气流受限的疾病,在全球发病率很高。本研究的目的是评估人工智能(AI)如何应用于该疾病的管理,分析提出的目标、使用的算法及其提供的结果。

方法

我们按照Arksey和O'Malley(2005年)以及Levac等人(2010年)的指南进行了一项范围综述。两名评审员独立地从五个数据库(Web of Science、PubMed、Scopus、Cinahl和Cochrane)的论文中搜索、分析和提取数据。纳入的研究必须应用一些AI技术来管理COPD临床过程的至少一个阶段。如果两名评审员之间存在任何差异,则以第三名评审员的标准为准。

结果

通过数据库搜索识别出380篇论文。应用排除标准后,67篇论文被纳入研究。这些研究性质各异,追求广泛的目标,主要突出那些侧重于疾病识别、分类和预防的目标。神经网络、支持向量机和决策树是最常用的AI算法。所有评估的性能指标的平均值和中位数在80%至90%之间。

结论

获得的结果表明,人们对开发管理COPD临床过程不同阶段的医学应用,尤其是预测模型,越来越感兴趣。根据所示的性能,这些模型可能是健康专家决策中有用的辅助工具,尽管需要更多高质量的机器学习研究来支持本研究的结果。

相似文献

1
Analyzing the use of artificial intelligence for the management of chronic obstructive pulmonary disease (COPD).分析人工智能在慢性阻塞性肺疾病(COPD)管理中的应用。
Int J Med Inform. 2021 Nov 9;158:104640. doi: 10.1016/j.ijmedinf.2021.104640.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.用于检测疑似痴呆患者额颞叶痴呆的局部脑血流单光子发射计算机断层扫描
Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD010896. doi: 10.1002/14651858.CD010896.pub2.
7
Artificial intelligence for detecting keratoconus.人工智能在圆锥角膜检测中的应用。
Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD014911. doi: 10.1002/14651858.CD014911.pub2.
8
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
9
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
10
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.

引用本文的文献

1
AI Applications for Chronic Condition Self-Management: Scoping Review.人工智能在慢性病自我管理中的应用:范围综述
J Med Internet Res. 2025 Apr 8;27:e59632. doi: 10.2196/59632.
2
Development and validation of a novel AI-derived index for predicting COPD medical costs in clinical practice.一种用于预测临床实践中慢性阻塞性肺疾病医疗费用的新型人工智能衍生指数的开发与验证
Comput Struct Biotechnol J. 2025 Jan 27;27:541-547. doi: 10.1016/j.csbj.2025.01.015. eCollection 2025.
3
Implementation of an algorithm for predicting exacerbations in telemonitoring: A multimethod study of patients' and clinicians' experiences.
远程监测中预测病情加重算法的实施:一项关于患者和临床医生体验的多方法研究
Int J Nurs Stud Adv. 2024 Oct 22;7:100257. doi: 10.1016/j.ijnsa.2024.100257. eCollection 2024 Dec.
4
Does adherence to exacerbation action plans matter? Insights from two COPD self-management studies.坚持加重期行动计划重要吗?两项慢性阻塞性肺疾病自我管理研究的见解。
Heliyon. 2024 Oct 10;10(20):e39070. doi: 10.1016/j.heliyon.2024.e39070. eCollection 2024 Oct 30.
5
Examining the effectiveness of artificial intelligence applications in asthma and COPD outpatient support in terms of patient health and public cost: SWOT analysis.探讨人工智能应用在哮喘和 COPD 门诊支持中对患者健康和公共成本的有效性:SWOT 分析。
Medicine (Baltimore). 2024 Jul 19;103(29):e38998. doi: 10.1097/MD.0000000000038998.
6
Revolutionizing Cardiology through Artificial Intelligence-Big Data from Proactive Prevention to Precise Diagnostics and Cutting-Edge Treatment-A Comprehensive Review of the Past 5 Years.通过人工智能革新心脏病学——从主动预防到精准诊断与前沿治疗的大数据——过去五年的全面综述
Diagnostics (Basel). 2024 May 26;14(11):1103. doi: 10.3390/diagnostics14111103.
7
Integrating Artificial Intelligence in the Diagnosis of COPD Globally: A Way Forward.在全球范围内将人工智能整合到慢性阻塞性肺疾病的诊断中:前进之路。
Chronic Obstr Pulm Dis. 2024 Jan 25;11(1):114-120. doi: 10.15326/jcopdf.2023.0449.
8
Remote patient monitoring strategies and wearable technology in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的远程患者监测策略与可穿戴技术
Front Med (Lausanne). 2023 Aug 17;10:1236598. doi: 10.3389/fmed.2023.1236598. eCollection 2023.
9
Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case-control study.深度学习在数字听诊和超声中的间质性肺疾病和慢性阻塞性肺疾病的诊断和严重程度分层:一项观察性病例对照研究的临床方案。
BMC Pulm Med. 2023 Jun 2;23(1):191. doi: 10.1186/s12890-022-02255-w.